MKI67 and neoplasm: To assess the potential clinical relevance of c-cyclin E, we first compared c-cyclin E expression with clinicopathological features at initial diagnosis (age, tumor size, stage and grade) and markers of disease biology in current clinical use, including ER, PR, HER2 and Ki67 status.